Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating xerophthalmia

A composition and dry eye technology, applied in the field of medicine, to achieve the effect of reasonable formula, easy-to-obtain and simple ingredients

Inactive Publication Date: 2014-02-05
章玲
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But the search for more rational drugs never stops

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating xerophthalmia
  • Pharmaceutical composition for treating xerophthalmia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] The preparation of embodiment 1 decoction

[0013] Take 5 grams of Dingguicao, 8 grams of Xiaoqingyang, 9 grams of Niu Mateng, 10 grams of Wushihua, 5 grams of Shuangshenteng, 12 grams of Narcissus, 7 grams of Gu Yangteng, 5 grams of Baijiegu and 10 grams of Dibacao. gram, add 5000 milliliters of water, heat 5 hours at 90 ℃ in airtight container, be cooled to room temperature, filter, and filtrate is decoction of the present invention.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating xerophthalmia. The pharmaceutical composition is a medicament prepared from the following components in parts by weight: 1-10 parts of zornia diphylla pers, 2-10 parts of populuspseud-simoni, 5-20 parts of evergreen mucuna root and leaf, 5-25 parts of pentapetes phoenicea, 1-10 parts of hupeh bauhinia root, 10-30 parts of impatiens aquatillis hook, 1-10 parts of streptocaulon griffithii hook, 1-10 parts of ruellia neesiana and 5-15 parts of spreading violet. The pharmaceutical composition for treating xerophthalmia disclosed by the invention is prepared from natural crude drugs, is simple and available in components, and significant in curative effect, and can be used for effectively treating the xerophthalmia. Therefore, the pharmaceutical composition is very applicable to clinical popularization.

Description

technical field [0001] The invention relates to the field of medicine, in particular, the invention relates to a pharmaceutical composition for treating dry eye. Background technique [0002] Dry eye is one of the most common diseases in ophthalmology. With the development of modern technology, the number of patients with dry eye is also increasing rapidly. It is a group of ocular surface diseases with complex etiology and various clinical manifestations. Reduced and a series of eye discomfort. Such as: fatigue, dryness, burning, foreign body sensation and other symptoms. The current treatment is mainly to use artificial tears, etc., and the application of traditional Chinese medicine is also on the rise day by day, and there are many treatments. However, the search for more rational drugs never stops. Contents of the invention [0003] The object of the present invention is to provide a pharmaceutical composition for treating dry eye. [0004] In order to achieve the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/86A61P27/02
Inventor 王英婷
Owner 章玲
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com